Literature DB >> 17162216

Antigen-specific T-lymphocyte function after cord blood transplantation.

Geoff Cohen1, Shelly L Carter, Kenneth I Weinberg, Bernadette Masinsin, Eva Guinan, Joanne Kurtzberg, John E Wagner, Nancy A Kernan, Robertson Parkman.   

Abstract

It has not been possible to determine the singular contribution of naive T lymphocytes to antigen-specific immunity after hematopoietic stem cell transplantation (HSCT), because of the confounding effects of donor-derived antigen-specific T lymphocytes present in most hematopoietic stem cell (HSC) products. Because umbilical cord blood contains only naive T lymphocytes, we longitudinally evaluated the recipients of unrelated cord blood transplantation (UCBT) for the presence of T lymphocytes with specificity for herpesviruses, to determine the contribution of the naive T lymphocytes to antigen-specific immune reconstitution after HSCT. Antigen-specific T lymphocytes were detected early after UCBT (herpes simplex virus on day 29; cytomegalovirus on day 44; varicella zoster virus on day 94). Overall, 66 of 153 UCBT recipients developed antigen-specific T lymphocytes to 1 or more herpesviruses during the evaluation period. The likelihood of developing antigen-specific T lymphocyte function was not associated with immunophenotypic T lymphocyte reconstitution, transplant cell dose, primary disease, or acute and chronic graft-versus-host disease. These results indicate that naive T lymphocytes present in the HSC inoculum can contribute to the generation of antigen-specific T-lymphocyte immunity early after transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17162216      PMCID: PMC1794680          DOI: 10.1016/j.bbmt.2006.08.036

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  22 in total

1.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10

2.  Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

Authors:  P Ljungman; P Reusser; R de la Camara; H Einsele; D Engelhard; P Ribaud; K Ward
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

3.  Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans.

Authors:  M J Levin; R Parkman; M N Oxman; J M Rappeport; M Simpson; P L Leary
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors.

Authors:  D R Noel; R P Witherspoon; R Storb; K Atkinson; K Doney; E M Mickelson; H D Ochs; R P Warren; P L Weiden; E D Thomas
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

5.  Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation.

Authors:  D J Winston; E S Huang; M J Miller; C H Lin; W G Ho; R P Gale; R E Champlin
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

6.  TORCH serologies and specific IgM antibody determination in acquired and congenital infections.

Authors:  J C Fung; R C Tilton
Journal:  Ann Clin Lab Sci       Date:  1985 May-Jun       Impact factor: 1.256

7.  Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.

Authors:  Robertson Parkman; Geoff Cohen; Shelly L Carter; Kenneth I Weinberg; Bernadette Masinsin; Eva Guinan; Joanne Kurtzberg; John E Wagner; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2006-09       Impact factor: 5.742

8.  IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory.

Authors:  Derek C Lenz; Sabine K Kurz; Edward Lemmens; Stephen P Schoenberger; Jonathan Sprent; Michael B A Oldstone; Dirk Homann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

9.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

Authors:  P Reusser; S R Riddell; J D Meyers; P D Greenberg
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

Review 10.  Reconstructing immunity after allogeneic transplantation.

Authors:  Cynthia R Giver; Jian-Ming Li; Mohammad S Hossain; Sagar Lonial; Edmund K Waller
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more
  22 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Authors:  Colin de Haar; Maud Plantinga; Nina Jg Blokland; Niek P van Til; Thijs Wh Flinsenberg; Viggo F Van Tendeloo; Evelien L Smits; Louis Boon; Lotte Spel; Marianne Boes; Jaap Jan Boelens; Stefan Nierkens
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

Review 3.  Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation.

Authors:  J L Zakrzewski; A M Holland; M R M van den Brink
Journal:  J Mol Med (Berl)       Date:  2007-02-28       Impact factor: 4.599

4.  Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

Authors:  Krishna V Komanduri; Lisa S St John; Marcos de Lima; John McMannis; Steven Rosinski; Ian McNiece; Susan G Bryan; Indreshpal Kaur; Sean Martin; Eric D Wieder; Laura Worth; Laurence J N Cooper; Demetrios Petropoulos; Jeffrey J Molldrem; Richard E Champlin; Elizabeth J Shpall
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

5.  Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients.

Authors:  P Ke; X-B Bao; X-H Hu; J Zhuang; X-J Wu; Y-J Liu; X-F He; D-P Wu; S-L Xue; X Ma
Journal:  Bone Marrow Transplant       Date:  2017-10-30       Impact factor: 5.483

6.  Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis.

Authors:  Andreas Reiff; Bracha Shaham; Kenneth I Weinberg; Gay M Crooks; Robertson Parkman
Journal:  J Clin Immunol       Date:  2011-05-04       Impact factor: 8.317

7.  T-lymphocyte recovery and function after cord blood transplantation.

Authors:  Paul Szabolcs
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

8.  Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

Authors:  Ioannis Politikos; Jessica A Lavery; Patrick Hilden; Christina Cho; Taylor Borrill; Molly A Maloy; Sergio A Giralt; Marcel R M van den Brink; Miguel-Angel Perales; Juliet N Barker
Journal:  Blood Adv       Date:  2020-01-14

Review 9.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

Review 10.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.